{"nct_id":"NCT04325698","title":"A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC","status":"TERMINATED","status_verified_date":"2024-06","start_date":"2020-06-11","start_date_type":"ACTUAL","primary_completion_date":"2021-05-10","primary_completion_date_type":"ACTUAL","completion_date":"2021-05-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}